Hospital Hm Rosaleda Hm La Esperanza

The rheumatology department at Hospital Hm Rosaleda Hm La Esperanza is advancing treatments for autoimmune conditions, notably rheumatoid arthritis, by evaluating innovative small‑molecule inhibitors and biologics aimed at reducing inflammation and improving patient outcomes.

• Evaluation of a TNFR1 signaling inhibitor in moderate‑to‑severe rheumatoid arthritis
• Assessment of anti‑inflammatory therapy for erosive hand osteoarthritis
• Investigation of novel agents targeting synovitis in knee osteoarthritis

The site is conducting 10 clinical studies with a team of 5 investigators, contributing valuable data to the field of immune‑mediated rheumatic diseases.

Research at the department emphasizes pain management and joint health for conditions such as knee osteoarthritis, erosive hand osteoarthritis, and chronic non‑specific low back pain, testing new therapies that aim to alleviate symptoms and preserve joint structure.

• Pain reduction strategies for knee osteoarthritis
• Structural modification of the tibiofemoral compartment in osteoarthritic knees
• Dose‑response evaluation of treatments for chronic low back pain
• Therapeutic options for erosive hand osteoarthritis

These investigations support the goal of improving functional ability and quality of life for patients with musculoskeletal disorders.

The unit explores the link between excess body weight and joint degeneration, focusing on interventions that promote weight loss while reducing pain in individuals with overweight or obesity and concurrent knee osteoarthritis.

• Weight‑loss efficacy of combined pharmacologic and lifestyle programs in obese patients with knee osteoarthritis
• Impact of metabolic health improvement on osteoarthritis‑related pain
• Integrated approaches targeting obesity and joint inflammation

By addressing metabolic risk factors, the research aims to enhance long‑term joint health and overall well‑being.